<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35159209</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Rapid Generation of Ventral Spinal Cord-like Astrocytes from Human iPSCs for Modeling Non-Cell Autonomous Mechanisms of Lower Motor Neuron Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">399</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11030399</ELocationID><Abstract><AbstractText>Astrocytes play important roles in the function and survival of neuronal cells. Dysfunctions of astrocytes are associated with numerous disorders and diseases of the nervous system, including motor neuron diseases such as amyotrophic lateral sclerosis (ALS). Human-induced pluripotent stem cell (iPSC)-based approaches are becoming increasingly important for the study of the mechanisms underlying the involvement of astrocytes in non-cell autonomous processes of motor neuron degeneration in ALS. These studies must account for the molecular and functional diversity among astrocytes in different regions of the brain and spinal cord. It is essential that the most pathologically relevant astrocyte preparations are used when investigating non-cell autonomous mechanisms of either upper or lower motor neuron degeneration in ALS. Here, we describe the efficient and streamlined generation of human iPSC-derived astrocytes with molecular and biological properties similar to physiological astrocytes in the ventral spinal cord. These induced astrocytes exhibit spontaneous and ATP-induced calcium transients, and lack signs of overt activation. Human iPSC-derived astrocytes with ventral spinal cord features offer advantages over more generic astrocyte preparations for the study of both ventral spinal cord astrocyte biology and the involvement of astrocytes in mechanisms of lower motor neuron degeneration in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soubannier</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0347-1364</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaineau</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9705-0754</Identifier><AffiliationInfo><Affiliation>Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gursu</LastName><ForeName>Lale</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haghi</LastName><ForeName>Ghazal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco Flores</LastName><ForeName>Anna Kristyna</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouleau</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durcan</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-3942-1956</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stifani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocyte</Keyword><Keyword MajorTopicYN="N">human-induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">lower motor neuron</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35159209</ArticleId><ArticleId IdType="pmc">PMC8834281</ArticleId><ArticleId IdType="doi">10.3390/cells11030399</ArticleId><ArticleId IdType="pii">cells11030399</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wahis J., Hennes M., Arckens L., Holt M.G. Star power: The emerging role of astrocytes as neuronal partners during cortical plasticity. Curr. Opin. Neurobiol. 2021;67:174&#x2013;182. doi: 10.1016/j.conb.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC8202513</ArticleId><ArticleId IdType="pubmed">33360483</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.X., Burrus Lane C.J., Eroglu C. Role of astrocytes in synapse formation and maturation. Curr. Top. Dev. Biol. 2021;142:371&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">33706922</ArticleId></ArticleIdList></Reference><Reference><Citation>Han R.T., Kim R.D., Molofsky A.V., Liddelow S.A. Astrocyte-immune cell interactions in physiology and pathology. Immunity. 2021;54:211&#x2013;224. doi: 10.1016/j.immuni.2021.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.01.013</ArticleId><ArticleId IdType="pubmed">33567261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayraktar O.A., Fuentealba L.C., Alvarez-Buylla A., Rowitch D.H. Astrocyte Development and Heterogeneity. Cold Spring Harb. Perspect. Biol. 2014;7:a020362. doi: 10.1101/cshperspect.a020362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020362</ArticleId><ArticleId IdType="pmc">PMC4292163</ArticleId><ArticleId IdType="pubmed">25414368</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata H. Diverse subtypes of astrocytes and their development during corticogenesis. Front. Neurosci. 2015;9:114. doi: 10.3389/fnins.2015.00114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00114</ArticleId><ArticleId IdType="pmc">PMC4387540</ArticleId><ArticleId IdType="pubmed">25904839</ArticleId></ArticleIdList></Reference><Reference><Citation>Khakh B.S., Deneen B. The Emerging Nature of Astrocyte Diversity. Annu. Rev. Neurosci. 2019;42:187&#x2013;207. doi: 10.1146/annurev-neuro-070918-050443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050443</ArticleId><ArticleId IdType="pubmed">31283899</ArticleId></ArticleIdList></Reference><Reference><Citation>De Majo M., Koontz M., Rowitch D., Ullian E.M. An update on human astrocytes and their role in development and disease. Glia. 2020;68:685&#x2013;704. doi: 10.1002/glia.23771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23771</ArticleId><ArticleId IdType="pubmed">31926040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Barres B.A. Astrocyte heterogeneity: An underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010;20:588&#x2013;594. doi: 10.1016/j.conb.2010.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2010.06.005</ArticleId><ArticleId IdType="pubmed">20655735</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberheim N.A., Goldman S.A., Nedergaard M. Heterogeneity of astrocytic form and function. Methods Mol. Biol. 2012;814:23&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3506190</ArticleId><ArticleId IdType="pubmed">22144298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgaard I., Os&#xf3;rio M.J., Kress B.T., Sanggaard S., Nedergaard M. White matter astrocytes in health and disease. Neuroscience. 2014;276:161&#x2013;173. doi: 10.1016/j.neuroscience.2013.10.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.10.050</ArticleId><ArticleId IdType="pmc">PMC4016995</ArticleId><ArticleId IdType="pubmed">24231735</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon H., Walters G., Paulsen A.R., Scarisbrick I.A. Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination. PLoS ONE. 2017;12:e0180697. doi: 10.1371/journal.pone.0180697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180697</ArticleId><ArticleId IdType="pmc">PMC5507262</ArticleId><ArticleId IdType="pubmed">28700615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurga A.M., Paleczna M., Kadluczka J., Kuter K.Z. Beyond the GFAP-Astrocyte Protein Markers in the Brain. Biomolecules. 2021;11:1361. doi: 10.3390/biom11091361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11091361</ArticleId><ArticleId IdType="pmc">PMC8468264</ArticleId><ArticleId IdType="pubmed">34572572</ArticleId></ArticleIdList></Reference><Reference><Citation>Krencik R., Zhang S.C. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat. Protoc. 2011;6:1710&#x2013;1717. doi: 10.1038/nprot.2011.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.405</ArticleId><ArticleId IdType="pmc">PMC3198813</ArticleId><ArticleId IdType="pubmed">22011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdad L., D&#x2019;Souza S.L., Kothari H.P., Qadeer Z.A., Germano I.M. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev. 2012;21:404&#x2013;410. doi: 10.1089/scd.2010.0560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2010.0560</ArticleId><ArticleId IdType="pubmed">21631388</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaltouki A., Peng J., Liu Q., Rao M.S., Zeng X. Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells. 2013;31:941&#x2013;952. doi: 10.1002/stem.1334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1334</ArticleId><ArticleId IdType="pubmed">23341249</ArticleId></ArticleIdList></Reference><Reference><Citation>Pa&#x15f;ca A.M., Sloan S.A., Clarke L.E., Tian Y., Makinson C.D., Huber N., Kim C.H., Park J.Y., O&#x2019;Rourke N.A., Nguyen K.D., et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods. 2015;12:671&#x2013;678. doi: 10.1038/nmeth.3415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3415</ArticleId><ArticleId IdType="pmc">PMC4489980</ArticleId><ArticleId IdType="pubmed">26005811</ArticleId></ArticleIdList></Reference><Reference><Citation>Tcw J., Wang M., Pimenova A.A., Bowles K.R., Hartley B.J., Lacin E., Machlovi S.I., Abdelaal R., Karch C.M., Phatnani H., et al. An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells. Stem Cell Rep. 2017;9:600&#x2013;614. doi: 10.1016/j.stemcr.2017.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.018</ArticleId><ArticleId IdType="pmc">PMC5550034</ArticleId><ArticleId IdType="pubmed">28757165</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C., Petrucelli L. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron. 2019;101:1057&#x2013;1069. doi: 10.1016/j.neuron.2019.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.032</ArticleId><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Chew Y.L., Lum J.S., Geraghty N.J., Yerbury J.J., Cashman N.R. Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises. Front Cell. Neurosci. 2020;14:581907. doi: 10.3389/fncel.2020.581907.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.581907</ArticleId><ArticleId IdType="pmc">PMC7671971</ArticleId><ArticleId IdType="pubmed">33328890</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Patani R. Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis. Stem Cells. 2018;36:293&#x2013;303. doi: 10.1002/stem.2758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2758</ArticleId><ArticleId IdType="pubmed">29235200</ArticleId></ArticleIdList></Reference><Reference><Citation>Izrael M., Slutsky S.G., Revel M. Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease. Front. Neurosci. 2020;14:824. doi: 10.3389/fnins.2020.00824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00824</ArticleId><ArticleId IdType="pmc">PMC7399224</ArticleId><ArticleId IdType="pubmed">32848579</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahsen B.F., Gray E., Thompson A.G., Ansorge O., Anthony D.C., Cowley S.A., Talbot K., Turner M.R. Non-neuronal cells in amyotrophic lateral sclerosis&#x2013;From pathogenesis to biomarkers. Nat. Rev. Neurol. 2021;17:333&#x2013;348. doi: 10.1038/s41582-021-00487-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00487-8</ArticleId><ArticleId IdType="pubmed">33927394</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Bogaert E., Dewil M., Hersmus N., Kiraly D., Scheveneels W., Bockx I., Braeken D., Verpoorten N., Verhoeven K., et al. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc. Natl. Acad. Sci. USA. 2007;104:14825&#x2013;14830. doi: 10.1073/pnas.0705046104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705046104</ArticleId><ArticleId IdType="pmc">PMC1976195</ArticleId><ArticleId IdType="pubmed">17804792</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Rodriguez-Muela N., Klim J.R., de Boer A.S., Agrawal S., Sandoe J., Lopes C.S., Ogliari K.S., Williams L.A., Shear M., et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-&#x3b2;1. Stem Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M.A., Castelli L.M., O&#x2019;Neill B., Kim Y., Talbot J., Nyberg S., Nyamali I., Heath P.R., Stopford M.J., et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Rouleau G.A., Ravits J., Cashman N.R. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS) Cold Spring Harb. Perspect. Med. 2017;7:a024117. doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin A.M.G., Shadfar S., Vidal M., Jamali M.S., Atkin J.D. Motor Neuron Susceptibility in ALS/FTD. Front Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifani S. Taking Cellular Heterogeneity into Consideration when Modeling Astrocyte Involvement in Amyotrophic Lateral Sclerosis Using Human Induced Pluripotent Stem Cells. Front. Cell. Neurosci. 2021;15:707861. doi: 10.3389/fncel.2021.707861.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.707861</ArticleId><ArticleId IdType="pmc">PMC8485040</ArticleId><ArticleId IdType="pubmed">34602979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.X., Abdian N., Maussion G., Thomas R.A., Demirova I., Cai E., Tabatabaei M., Beitel L.K., Karamchandani J., Fon E.A., et al. A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types. Methods Protoc. 2021;4:50. doi: 10.3390/mps4030050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mps4030050</ArticleId><ArticleId IdType="pmc">PMC8293472</ArticleId><ArticleId IdType="pubmed">34287353</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z.W., Chen H., Liu H., Lu J., Qian K., Huang C.L., Zhong X., Fan F., Zhang S.C. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 2015;6:6626. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiry L., Hamel R., Pluchino S., Durcan T., Stifani S. Characterization of Human iPSC-derived Spinal Motor Neurons by Single-cell RNA Sequencing. Neuroscience. 2020;450:57&#x2013;70. doi: 10.1016/j.neuroscience.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.04.041</ArticleId><ArticleId IdType="pubmed">32380268</ArticleId></ArticleIdList></Reference><Reference><Citation>Methot L., Soubannier V., Hermann R., Campos E., Li S., Stifani S. Nuclear factor-kappaB regulates multiple steps of gliogenesis in the developing murine cerebral cortex. Glia. 2018;66:2659&#x2013;2672. doi: 10.1002/glia.23518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23518</ArticleId><ArticleId IdType="pubmed">30338559</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubannier V., Maussion G., Chaineau M., Sigutova V., Rouleau G., Durcan T.M., Stifani S. Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery. Neurosci Lett. 2020;731:135028. doi: 10.1016/j.neulet.2020.135028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135028</ArticleId><ArticleId IdType="pubmed">32380146</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101&#x2013;1108. doi: 10.1038/nprot.2008.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.73</ArticleId><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Moein M., Grzyb K., Martins T.G., Komoto S., Peri F., Crawford A.D., D&#x2019;Herouel A.F., Skupin A. CaSiAn: A Calcium Signaling Analyzer tool. Bioinformatics. 2018;34:3052&#x2013;3054. doi: 10.1093/bioinformatics/bty281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty281</ArticleId><ArticleId IdType="pmc">PMC6129310</ArticleId><ArticleId IdType="pubmed">29668830</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumlauf R. Hox genes, clusters and collinearity. Int. J. Dev. Biol. 2018;62:659&#x2013;663. doi: 10.1387/ijdb.180330rr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1387/ijdb.180330rr</ArticleId><ArticleId IdType="pubmed">30604835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson J.C., Lemons D., McGinnis W. Modulating Hox gene functions during animal body patterning. Nat. Rev. Genet. 2005;6:893&#x2013;904. doi: 10.1038/nrg1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg1726</ArticleId><ArticleId IdType="pubmed">16341070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley R.A., Shireman J., McFalls C., Choi J., Canfield S.G., Dong Y., Liu K., Lisota B., Jones J.R., Petersen A., et al. Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties. Development. 2019;146:dev170910. doi: 10.1242/dev.170910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.170910</ArticleId><ArticleId IdType="pmc">PMC6633609</ArticleId><ArticleId IdType="pubmed">31189664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou P.S., hAil&#xed;n D.&#xd3;., Vogel T., Hanashima C. Transcription and Beyond: Delineating FOXG1 Function in Cortical Development and Disorders. Front. Cell. Neurosci. 2020;14:35. doi: 10.3389/fncel.2020.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00035</ArticleId><ArticleId IdType="pmc">PMC7052011</ArticleId><ArticleId IdType="pubmed">32158381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagner A., Briscoe J. Establishing neuronal diversity in the spinal cord: A time and a place. Development. 2019;146:dev182154. doi: 10.1242/dev.182154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.182154</ArticleId><ArticleId IdType="pubmed">31767567</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung B., Shimeld S.M. Evolution of vertebrate spinal cord patterning. Dev. Dyn. 2019;248:1028&#x2013;1043. doi: 10.1002/dvdy.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.77</ArticleId><ArticleId IdType="pubmed">31291046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002;110:385&#x2013;397. doi: 10.1016/S0092-8674(02)00835-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00835-8</ArticleId><ArticleId IdType="pubmed">12176325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochstim C., Deneen B., Lukaszewicz A., Zhou Q., Anderson D.J. Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell. 2008;133:510&#x2013;522. doi: 10.1016/j.cell.2008.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.02.046</ArticleId><ArticleId IdType="pmc">PMC2394859</ArticleId><ArticleId IdType="pubmed">18455991</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen M.L., Campbell S.L., Sontheimer H. Differential distribution of Kir4.1 in spinal cord astrocytes suggests regional differences in K+ homeostasis. J. Neurophysiol. 2007;98:786&#x2013;793. doi: 10.1152/jn.00340.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00340.2007</ArticleId><ArticleId IdType="pmc">PMC2040512</ArticleId><ArticleId IdType="pubmed">17581847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley K.W., Ben Haim L., Schirmer L., Tyzack G.E., Tolman M., Miller J.G., Tsai H.H., Chang S.M., Molofsky A.V., Yang Y., et al. Kir4.1-Dependent Astrocyte-Fast Motor Neuron Interactions Are Required for Peak Strength. Neuron. 2018;98:306&#x2013;319.e7. doi: 10.1016/j.neuron.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.03.010</ArticleId><ArticleId IdType="pmc">PMC5919779</ArticleId><ArticleId IdType="pubmed">29606582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivonkova H., Benesova J., Butenko O., Chvatal A., Anderova M. Impact of global cerebral ischemia on K+ channel expression and membrane properties of glial cells in the rat hippocampus. Neurochem. Int. 2010;57:783&#x2013;794. doi: 10.1016/j.neuint.2010.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2010.08.016</ArticleId><ArticleId IdType="pubmed">20833221</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen M.L., Campbell S.C., McFerrin M.B., Floyd C.L., Sontheimer H. Spinal cord injury causes a wide-spread, persistent loss of Kir4.1 and glutamate transporter 1: Benefit of 17 beta-oestradiol treatment. Pt 4Brain. 2010;133:1013&#x2013;1025. doi: 10.1093/brain/awq049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq049</ArticleId><ArticleId IdType="pmc">PMC2850584</ArticleId><ArticleId IdType="pubmed">20375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo M., Schmitt L.I., Steffen R., Kutritz A., Kleinschnitz C., Hagenacker T. Modulation of Glutamate Transporter EAAT1 and Inward-Rectifier Potassium Channel Kir4.1 Expression in Cultured Spinal Cord Astrocytes by Platinum-Based Chemotherapeutics. Int. J. Mol. Sci. 2021;22:6300. doi: 10.3390/ijms22126300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126300</ArticleId><ArticleId IdType="pmc">PMC8230757</ArticleId><ArticleId IdType="pubmed">34208258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagelhus E.A., Mathiisen T.M., Ottersen O.P. Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience. 2004;129:905&#x2013;913. doi: 10.1016/j.neuroscience.2004.08.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.08.053</ArticleId><ArticleId IdType="pubmed">15561407</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohschein S., H&#xfc;ttmann K., Gabriel S., Binder D.K., Heinemann U., Steinh&#xe4;user C. Impact of aquaporin-4 channels on K+ buffering and gap junction coupling in the hippocampus. Glia. 2011;59:973&#x2013;980. doi: 10.1002/glia.21169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21169</ArticleId><ArticleId IdType="pubmed">21446052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeshima-Kataoka H. Neuroimmunological Implications of AQP4 in Astrocytes. Int. J. Mol. Sci. 2016;17:1306. doi: 10.3390/ijms17081306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17081306</ArticleId><ArticleId IdType="pmc">PMC5000703</ArticleId><ArticleId IdType="pubmed">27517922</ArticleId></ArticleIdList></Reference><Reference><Citation>Batavelji&#x107; D., Nikoli&#x107; L., Milosevi&#x107; M., Todorovi&#x107; N., Andjus P.R. Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model. Glia. 2012;60:1991&#x2013;2003. doi: 10.1002/glia.22414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22414</ArticleId><ArticleId IdType="pubmed">22987392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser M., Maletzki I., H&#xfc;lsmann S., Holtmann B., Schulz-Schaeffer W., Kirchhoff F., B&#xe4;hr M., Neusch C. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2006;99:900&#x2013;912. doi: 10.1111/j.1471-4159.2006.04131.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.04131.x</ArticleId><ArticleId IdType="pubmed">16925593</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Barres B.A. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity. 2017;46:957&#x2013;967. doi: 10.1016/j.immuni.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke L.E., Liddelow S.A., Chakraborty C., Munch A.E., Heiman M., Barres B.A. Normal aging induces A1-like astrocyte reactivity. Proc. Natl. Acad. Sci. USA. 2018;115:E1896&#x2013;E1905. doi: 10.1073/pnas.1800165115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800165115</ArticleId><ArticleId IdType="pmc">PMC5828643</ArticleId><ArticleId IdType="pubmed">29437957</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian J.L., Xu L., Foo L.C., Nouri N., Zhou L., Giffard R.G., Barres B.A. Genomic analysis of reactive astrogliosis. J. Neurosci. 2012;32:6391&#x2013;6410. doi: 10.1523/JNEUROSCI.6221-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6221-11.2012</ArticleId><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>John G.R., Chen L., Rivieccio M.A., Melendez-Vasquez C.V., Hartley A., Brosnan C.F. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J. Neurosci. 2004;24:2837&#x2013;2845. doi: 10.1523/JNEUROSCI.4789-03.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4789-03.2004</ArticleId><ArticleId IdType="pmc">PMC6729504</ArticleId><ArticleId IdType="pubmed">15028778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillen A.E.J., Burbach J.P.H., Hol E.M. Cell adhesion and matricellular support by astrocytes of the tripartite synapse. Prog. Neurobiol. 2018;165:66&#x2013;86. doi: 10.1016/j.pneurobio.2018.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2018.02.002</ArticleId><ArticleId IdType="pubmed">29444459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson E. Actin filament reorganization in astrocyte networks is a key functional step in neuroinflammation resulting in persistent pain: Novel findings on network restoration. Neurochem. Res. 2015;40:372&#x2013;379. doi: 10.1007/s11064-014-1363-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-014-1363-6</ArticleId><ArticleId IdType="pubmed">24952067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Hall C.E., Sibley C.R., Cymes T., Forostyak S., Carlino G., Meyer I.F., Schiavo G., Zhang S.-C., Gibbons G.M., et al. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun. 2017;8:1164. doi: 10.1038/s41467-017-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01283-z</ArticleId><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigetomi E., Patel S., Khakh B.S. Probing the Complexities of Astrocyte Calcium Signaling. Trends Cell. Biol. 2016;26:300&#x2013;312. doi: 10.1016/j.tcb.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.01.003</ArticleId><ArticleId IdType="pmc">PMC4946798</ArticleId><ArticleId IdType="pubmed">26896246</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazargani N., Attwell D. Astrocyte calcium signaling: The third wave. Nat. Neurosci. 2016;19:182&#x2013;189. doi: 10.1038/nn.4201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4201</ArticleId><ArticleId IdType="pubmed">26814587</ArticleId></ArticleIdList></Reference><Reference><Citation>Adami R., Bottai D. Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies. Stem Cell Rev. Rep. 2019;15:795&#x2013;813. doi: 10.1007/s12015-019-09910-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09910-6</ArticleId><ArticleId IdType="pubmed">31863335</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern M., Brennand K.J., Gregory J. Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs. Neurobiol. Dis. 2019;132:104562. doi: 10.1016/j.nbd.2019.104562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104562</ArticleId><ArticleId IdType="pmc">PMC6834907</ArticleId><ArticleId IdType="pubmed">31381978</ArticleId></ArticleIdList></Reference><Reference><Citation>Slanzi A., Iannoto G., Rossi B., Zenaro E., Constantin G. In vitro Models of Neurodegenerative Diseases. Front. Cell Dev. Biol. 2020;8:328. doi: 10.3389/fcell.2020.00328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00328</ArticleId><ArticleId IdType="pmc">PMC7247860</ArticleId><ArticleId IdType="pubmed">32528949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J., Imhof S., Wainger B.J. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol. Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.E., Yao Z., Choi M., Tyzack G.E., Serio A., Luisier R., Harley J., Preza E., Arber C., Crisp S.J., et al. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS. Cell Rep. 2017;19:1739&#x2013;1749. doi: 10.1016/j.celrep.2017.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.024</ArticleId><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Roybon L., Lamas N.J., Garcia A.D., Yang E.J., Sattler R., Lewis V.J., Kim Y.A., Kachel C.A., Rothstein J.D., Przedborski S., et al. Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep. 2013;4:1035&#x2013;1048. doi: 10.1016/j.celrep.2013.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.021</ArticleId><ArticleId IdType="pmc">PMC4229657</ArticleId><ArticleId IdType="pubmed">23994478</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Devlin A.C., Chouhan A.K., Selvaraj B.T., Stavrou M., Burr K., Brivio V., He X., Mehta A.R., Story D., et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68:1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise C., Soyfoo M.S., Authelet M., De Decker R., Bataveljic D., Delporte C., Pochet R. Aquaporin-4 overexpression in rat ALS model. Anat. Rec. 2009;292:207&#x2013;213. doi: 10.1002/ar.20838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.20838</ArticleId><ArticleId IdType="pubmed">19089902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Masaki K., Yamasaki R., Imamura S., Suzuki S.O., Hayashi S., Sato S., Nagara Y., Kawamura M.F., Kira J. Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model. J. Neuroinflamm. 2014;11:42. doi: 10.1186/1742-2094-11-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-42</ArticleId><ArticleId IdType="pmc">PMC4016493</ArticleId><ArticleId IdType="pubmed">24597481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou S., Lan Y.L., Wang H., Zhang B., Sun Y.G. The potential roles of aquaporin 4 in amyotrophic lateral sclerosis. Neurol. Sci. 2019;40:1541&#x2013;1549. doi: 10.1007/s10072-019-03877-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03877-5</ArticleId><ArticleId IdType="pubmed">30980198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong K.C., Mehta A.R., Nedergaard M., Chandran S. Defining novel functions for cerebrospinal fluid in ALS pathophysiology. Acta Neuropathol. Commun. 2020;8:140. doi: 10.1186/s40478-020-01018-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01018-0</ArticleId><ArticleId IdType="pmc">PMC7439665</ArticleId><ArticleId IdType="pubmed">32819425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Sequeira C., Barbosa M., Cunha C., Vaz A.R., Brites D. Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes. Exp. Cell Res. 2020;395:112209. doi: 10.1016/j.yexcr.2020.112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112209</ArticleId><ArticleId IdType="pubmed">32739211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V., Re D.B., Le Verche V., Alvarez M.J., Vasciaveo A., Jacquier A., Doulias P.T., Greco T.M., Nizzardo M., Papadimitriou D., et al. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nat. Commun. 2020;11:5579. doi: 10.1038/s41467-020-19177-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19177-y</ArticleId><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y.J., Halliday G.M., Holton J.L., Lashley T., O&#x2019;Sullivan S.S., McCann H., Lees A.J., Ozawa T., Williams D.R., Lockhart P.J., et al. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J. Neuropathol. Exp. Neurol. 2009;68:1073&#x2013;1083. doi: 10.1097/NEN.0b013e3181b66f1b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181b66f1b</ArticleId><ArticleId IdType="pubmed">19918119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>